Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma

被引:24
|
作者
Tarasova, V. D. [1 ]
Tuttle, R. M. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Serv Endocrinol, 1275 York Ave, New York, NY 10021 USA
关键词
Low risk thyroid cancer; papillary microcarcinoma; staging; BRAF V600E MUTATION; ACTIVE SURVEILLANCE; RADIOACTIVE IODINE; CARCINOMA; ASSOCIATION; RECURRENCE; STRATIFICATION; SURGERY; PROGNOSIS; IMPACT;
D O I
10.1016/j.clon.2016.12.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Each year, the proportion of thyroid cancer patients presenting with low risk disease is increasing. Moreover, the definition of low risk thyroid cancer is expanding and several histological subtypes beyond papillary microcarcinomas are now classified as low risk disease. This shift in the landscape of thyroid cancer presentation is forcing clinicians to critically re-evaluate whether or not traditional management paradigms that were effective in treating intermediate and high risk disease are applicable to these low risk patients. Here we review the definition of low risk disease, examine the various histological subtypes that are considered low risk in the 2015 American Thyroid Association guidelines for the management of thyroid nodules and thyroid cancer, and review our current approach to the management of these low risk tumours. (C) 2016 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
引用
收藏
页码:290 / 297
页数:8
相关论文
共 50 条
  • [21] BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk Management
    Mingzhao Xing
    Annals of Surgical Oncology, 2009, 16 : 801 - 803
  • [22] BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk Management
    Xing, Mingzhao
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (04) : 801 - 803
  • [23] An update on the management of low-risk differentiated thyroid cancer
    Lamartina, Livia
    Leboulleux, Sophie
    Terroir, Marie
    Hartl, Dana
    Schlumberger, Martin
    ENDOCRINE-RELATED CANCER, 2019, 26 (11) : R597 - R610
  • [24] Overview on surgical management of papillary thyroid microcarcinoma
    Ruggiero, R.
    Pirozzi, R.
    Gualtieri, G.
    Terracciano, G.
    Parisi, S.
    Nesta, G.
    Gazeneo, L.
    Volpe, M. Lanza
    Rinaldi, S.
    Docimo, L.
    GIORNALE DI CHIRURGIA, 2019, 40 (02): : 81 - 87
  • [25] Controversies in the Management of Low-Risk Differentiated Thyroid Cancer
    Haymart, Megan R.
    Esfandiari, Nazanene H.
    Stang, Michael T.
    Sosa, Julia Ann
    ENDOCRINE REVIEWS, 2017, 38 (04) : 351 - 378
  • [26] Trends in nonoperative management of papillary thyroid microcarcinoma
    Holoubeck, Simon A.
    Yan, Huan
    Kuchta, Kristine M.
    Winchester, David J.
    Moo-Young, Tricia A.
    Prinz, Richard A.
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (06) : 952 - 957
  • [27] Controversy on papillary thyroid microcarcinoma management REPLY
    Mazeh, Haggi
    Chenand, Herbert
    NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (01) : 9 - 9
  • [28] Current trends in the management of well differentiated papillary thyroid carcinoma
    Solomon, BL
    Wartofsky, L
    Burman, KD
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (01): : 333 - 339
  • [29] Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid
    Oda, Hitomi
    Miyauchi, Akira
    Ito, Yasuhiro
    Sasai, Hisanori
    Masuoka, Hiroo
    Yabuta, Tomonori
    Fukushima, Mitsuhiro
    Higashiyama, Takuya
    Kihara, Minoru
    Kobayashi, Kaoru
    Miya, Akihiro
    ENDOCRINE JOURNAL, 2017, 64 (01) : 59 - 64
  • [30] THYROID PAPILLARY MICROCARCINOMA
    LEPRAT, F
    TROUETTE, H
    COCHET, C
    SAUMTHALLY, B
    MASSON, B
    DEMASCAREL, A
    LATAPIE, JL
    ANNALES D ENDOCRINOLOGIE, 1993, 54 (05) : 343 - 346